SMLR Stock Overview
Provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Semler Scientific, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$24.62 |
| 52 Week High | US$53.38 |
| 52 Week Low | US$20.88 |
| Beta | 0.97 |
| 11 Month Change | -15.40% |
| 3 Month Change | -17.58% |
| 1 Year Change | -7.96% |
| 33 Year Change | -77.41% |
| 5 Year Change | -41.38% |
| Change since IPO | 252.22% |
Recent News & Updates
Recent updates
Earnings Troubles May Signal Larger Issues for Semler Scientific (NASDAQ:SMLR) Shareholders
Aug 14
The Market Doesn't Like What It Sees From Semler Scientific, Inc.'s (NASDAQ:SMLR) Earnings Yet
Jul 18We Ran A Stock Scan For Earnings Growth And Semler Scientific (NASDAQ:SMLR) Passed With Ease
May 08Many Still Looking Away From Semler Scientific, Inc. (NASDAQ:SMLR)
Apr 17Is Now The Time To Put Semler Scientific (NASDAQ:SMLR) On Your Watchlist?
Jan 11Estimating The Intrinsic Value Of Semler Scientific, Inc. (NASDAQ:SMLR)
Dec 07What Does Semler Scientific, Inc.'s (NASDAQ:SMLR) Share Price Indicate?
Apr 07Calculating The Intrinsic Value Of Semler Scientific, Inc. (NASDAQ:SMLR)
Dec 14Semler Scientific: Growth, Profits, And Valuation Models Support A Buy
Aug 02Semler Scientific: A Small Company Solving A Big Problem
Apr 21Things Look Grim For Semler Scientific, Inc. (NASDAQ:SMLR) After Today's Downgrade
Mar 08Semler Scientific: Why I'm Buying
Mar 05Should You Investigate Semler Scientific, Inc. (NASDAQ:SMLR) At US$52.64?
Mar 02Semler's Unique Business Model Is Fueling Profitable Growth
Feb 23Better Price For Semler Is Likely
Jan 05Semler Scientific's (NASDAQ:SMLR) Earnings Are Weaker Than They Seem
Nov 12It Looks Like The CEO Of Semler Scientific, Inc. (NASDAQ:SMLR) May Be Underpaid Compared To Peers
Oct 15Semler Scientific: Rapidly Growing Medical Device Company
Oct 14There's Reason For Concern Over Semler Scientific, Inc.'s (NASDAQ:SMLR) Massive 28% Price Jump
Oct 14Shareholder Returns
| SMLR | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -14.5% | 0.5% | -1.9% |
| 1Y | -8.0% | 13.5% | 20.9% |
Return vs Industry: SMLR underperformed the US Medical Equipment industry which returned 12.1% over the past year.
Return vs Market: SMLR underperformed the US Market which returned 22.7% over the past year.
Price Volatility
| SMLR volatility | |
|---|---|
| SMLR Average Weekly Movement | 10.2% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: SMLR's share price has been volatile over the past 3 months.
Volatility Over Time: SMLR's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 92 | Doug Murphy-Chutorian | www.semlerscientific.com |
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing.
Semler Scientific, Inc. Fundamentals Summary
| SMLR fundamental statistics | |
|---|---|
| Market cap | US$186.69m |
| Earnings (TTM) | US$15.82m |
| Revenue (TTM) | US$61.74m |
10.9x
P/E Ratio2.8x
P/S RatioIs SMLR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SMLR income statement (TTM) | |
|---|---|
| Revenue | US$61.74m |
| Cost of Revenue | US$7.00m |
| Gross Profit | US$54.74m |
| Other Expenses | US$38.93m |
| Earnings | US$15.82m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.26 |
| Gross Margin | 88.67% |
| Net Profit Margin | 25.62% |
| Debt/Equity Ratio | 0% |
How did SMLR perform over the long term?
See historical performance and comparison